ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

ALLERGIC CONJUNCTIVITIS: PREVALENCE, SYMPTOMS, PRECIPITATING AND RISK FACTORS AMONG SAUDI POPULATION OF ARAR.

AUTHORS:

Mujeeb Ur Rehman Parrey, Abdulrhman Ahmed Alenazi, ‏Munif Saleh Alenezi, ‏‏Hamdan Ayed H Albathali, ‏ ‏Ahmed Saud A Aldaghmi

ABSTRACT:

Background: Allergic conjunctivitis (AC) is a common eye disease that can impair the quality of life of the affect-ed people. The most common allergens responsible for AC are pollens, chemicals, air pollution and smoke. Objective: In the current study we aimed to study the prevalence, symptoms, precipitating and risk factors for AC among Saudi population of Arar city in Northern Saudi Arabia. Methods: This cross-sectional, community-based study was conducted on 426 Saudi people living in Arar city. The prevalence, symptoms, precipitating and risk factors for AC were studied using a predesigned questionnaire. Data entry and statistical analysis were done using SPSS (statistical package for social sciences) Version 22. Results: The current study found that the prevalence of AC in Arar city is 51.5%. The main symptoms were itch-ing, red eyes, tearing and burning/foreign body sensation of the eyes in 66.9%, 59.7%, 39.5% and 21.8% of the studied participants respectively. The most common precipitating factors were air borne dust, hot and humid weather and exposure to chemicals e.g. perfumes in 68.5%, 30.6% and 29% cases respectively. Male were found to be more susceptible to AC than females (P>0.05) and there was significant association with age and positive fami-ly history of AC (P<0.05). Conclusion: The prevalence of AC is high in Arar city. Health education sessions about the nature of the disease and its precipitating and risk factors are recommended for better management of AC cases. Key words: Allergic conjunctivitis, Arar, prevalence, precipitating and risk factors, Saudi Arabia, symptoms.

FULL TEXT

Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.